Leadership Overview
Veranex has 4 executives leading key functions including strategy, financial operations, organizational scaling, and administrative infrastructure.
Focused on accelerating medical technology breakthroughs, Veranex delivers comprehensive research and development services to transform innovative concepts into market-ready solutions that improve patient outcomes across global cardiovascular, neurology, and biopharma sectors.
Focused on accelerating medical technology breakthroughs, Veranex delivers comprehensive research and development services to transform innovative concepts into market-ready solutions that improve patient outcomes across global cardiovascular, neurology, and biopharma sectors.
Leadership Roles at Veranex
Megan Osorio - Chief Executive Officer
Megan Osorio, the Chief Executive Officer at Veranex, directs the overarching strategic vision for the organization. By aligning clinical research, regulatory consulting, and commercialization services, Osorio ensures the company maintains a competitive edge within the medical device and in-vitro diagnostics sectors. This leadership role involves fostering partnerships with global clients to navigate complex development pathways. Megan Osorio drives the mission to transform innovative concepts into market-ready solutions, prioritizing efficiency and patient-centric outcomes. Through constant engagement with the Board, the Chief Executive Officer monitors market trends in cardiovascular and neurology fields to identify growth opportunities. By overseeing the integration of diverse service lines, the Chief Executive Officer secures long-term stability and operational excellence. Ultimately, Osorio positions the firm as a premier Innovation CRO, consistently delivering high-value results for stakeholders and patients alike.
.jpg)
Manasi Ramanna - Chief Financial Officer
Manasi Ramanna, the Chief Financial Officer at Veranex, manages the fiscal health and capital allocation strategies for the organization. Overseeing financial planning, reporting, and risk management, the Chief Financial Officer ensures the company possesses the necessary resources to support extensive clinical trials and regulatory consulting projects. Manasi Ramanna drives financial transparency and operational efficiency, enabling the firm to scale effectively across international markets. This leadership role requires close collaboration with other C-suite members to align budgetary priorities with long-term business objectives. By optimizing revenue cycles and investment in R&D infrastructure, the Chief Financial Officer supports the delivery of high-quality services to clients in the biopharma and medical device industries. Through rigorous analysis of market performance, Ramanna maintains the financial agility required to navigate the evolving healthcare landscape, ensuring sustained profitability and continued investment in cutting-edge medical technology solutions.
David Dockhorn - Chief Operating Officer
David Dockhorn, the Chief Operating Officer at Veranex, executes the daily operational strategy across all service divisions. Focusing on internal scaling and process optimization, the Chief Operating Officer ensures that design, development, and clinical research workflows meet rigorous industry standards. David Dockhorn drives the integration of cross-functional teams to streamline project delivery for global clients in the cardiovascular and ophthalmology fields. This leadership role involves managing resource allocation and operational capacity to handle complex regulatory and commercialization mandates. By implementing robust project management frameworks, the Chief Operating Officer enhances productivity and service quality. Dockhorn maintains alignment with the broader corporate mission by fostering a culture of operational excellence and continuous improvement. Through the oversight of technical operations, the Chief Operating Officer guarantees that every project phase remains on schedule, ultimately accelerating the path from concept to market-ready medical solutions.
Doug Dockhorn - Chief Administrative Officer (CAO)
Doug Dockhorn, the Chief Administrative Officer (CAO) at Veranex, architects the internal infrastructure and corporate governance frameworks necessary for organizational success. Overseeing human capital, facilities, and administrative systems, the Chief Administrative Officer (CAO) ensures that the company maintains a high-performance environment conducive to innovation. Doug Dockhorn drives the development of policies that support the firm's specialized knowledge base and long-term growth objectives. This leadership role involves coordinating with executive peers to ensure that administrative support aligns with the needs of clinical and regulatory teams. By managing corporate compliance and internal communications, the Chief Administrative Officer (CAO) fosters a cohesive organizational culture. Dockhorn prioritizes the optimization of internal systems to support the company's mission of transforming medical concepts into reality. Through the management of administrative operations, the Chief Administrative Officer (CAO) provides the foundational stability required for the firm to excel in the competitive medical device sector.

Explore Leadership Teams in Business Services
Quest Global is a global engineering services provider that delivers end-to-end engineering solutions across various industries, including Aerospace & Defense, Automotive, Hi-Tech, Energy & Utilities, Industrial, MedTech & Healthcare, Rail, and Semiconductors. With over 23,000 employees in 22 countries, they leverage deep industry knowledge and digital expertise to solve complex engineering challenges. Their services encompass a wide range of engineering disciplines, including software, embedded, mechanical, and digital engineering, among others. Quest Global aims to be the trusted partner for the world's hardest engineering problems, contributing to a brighter and more sustainable future.
Company Leadership DM
CS
JD

WCG Clinical Services enhances the quality and efficiency of clinical trials for biopharmaceutical companies, contract research organizations (CROs), and research institutions. They offer a range of solutions including study planning, independent ethical review, and data insights to facilitate the development of new treatments. Their expertise spans the research ecosystem, providing support to sponsors, CROs, sites, and participants. WCG Clinical Services is committed to accelerating research and improving patient outcomes through innovative technology and expert consulting.
Company Leadership GW
PM
TC
Worldwide Clinical Trials is a global, mid-sized CRO that provides top-performing, preclinical, and Phase I-IV clinical development services to the biotechnology and pharmaceutical industries. Founded in 1986, our full-service clinical experience ranges from early phase and bioanalytical sciences through late phase studies, post approval, and real-world evidence. Major therapeutic areas of focus include Cardiovascular, Metabolic, Neuroscience, Oncology, and Rare Diseases.
Company Leadership DJ


IDEXX Laboratories, Inc. develops, manufactures, and distributes products primarily for the companion animal veterinary, livestock and poultry, dairy, and water testing markets in Africa, the Asia Pacific, Canada, Europe, Latin America, and internationally. The company operates through three segments: Companion Animal Group; Water Quality Products; and Livestock, Poultry and Dairy. It also provides point-of-care veterinary diagnostic products, including instruments, consumables, and rapid assay test kits; veterinary reference laboratory diagnostic and consulting services; practice management and diagnostic imaging systems and services for veterinarians; and health monitoring, biological materials testing, and laboratory diagnostic instruments, and services for biomedical research community. In addition, the company offers diagnostic and health-monitoring products for livestock, poultry, and dairy; products that test water for various microbiological contaminants; point-of-care electrolytes and blood gas analyzers; in-clinic chemistry, blood and urine chemistry, hematology, immunoassay, urinalysis, and coagulation analyzers; and SNAP rapid assays test kits.
Company Leadership TB
MS
JR